Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-25 @ 3:20 PM
Study NCT ID:
NCT04003168
Status:
UNKNOWN
Last Update Posted:
2021-03-01
First Post:
2019-06-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma
Sponsor:
Hrain Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-24
First Submit QC Date:
None
Study First Post Date:
2019-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-25
Last Update Post Date:
2021-03-01
Last Update Post Date Type:
ACTUAL